-
公开(公告)号:EP2013182A2
公开(公告)日:2009-01-14
申请号:EP07753130.9
申请日:2007-03-13
发明人: COCIORVA, Oana , LI, Bei , SZARDENINGS, Katrin , FUKUDA, Yasumichi , NOMURA, Masahiro , SETO, Shigeki , YUMOTO, Kazuhiro , OKADA, Kyoko , NAKAMURA, Ayako
IPC分类号: C07D215/38 , C07D215/56 , C07D401/12 , C07D401/14 , C07D498/06 , A61K31/47 , A61K31/4709 , A61K31/538 , A61P25/00
CPC分类号: C12N9/99 , C07D498/06
摘要: Provided herein are aminoquinolones and pharmaceutically acceptable derivatives thereof. In certain embodiments, provided herein are compounds, compositions and methods for treating, preventing or ameliorating GSK-3 mediated diseases.
摘要翻译: 本文提供氨基喹诺酮及其药学上可接受的衍生物。 在某些实施方案中,本文提供了用于治疗,预防或改善GSK-3介导的疾病的化合物,组合物和方法。
-
公开(公告)号:EP2203459B1
公开(公告)日:2016-03-16
申请号:EP08830522.2
申请日:2008-09-12
发明人: COCIORVA, Oana , FUKUDA, Yasumichi , KOHNO, Yasushi , LI, Bei , OKADA, Kyoko , NAKAMURA, Ayako , NOMURA, Masahiro , SETO, Shigeki , SZARDENINGS, Katrin , YUMOTO, Kazuhiro
IPC分类号: C07D498/06 , A61J1/00 , C07D498/10 , C07D498/20
CPC分类号: C07D498/06 , A61J1/00 , C07D498/10 , C07D498/20
-
公开(公告)号:EP1862464A1
公开(公告)日:2007-12-05
申请号:EP06729621.0
申请日:2006-03-22
发明人: NOMURA, Masahiro , TAKANO, Yasuo , YUMOTO, Kazuhiro , OKADA, Kyoko , SHINOZAKI, Takehiro , ISOGAI, Shigeki
IPC分类号: C07D417/12
CPC分类号: C07D417/12 , C07D409/12
摘要: The present invention provides cyclic aminophenylalkanoic acid derivatives that act as agonists for human peroxisome proliferator-activated receptors (PPARs), in particular human PPARα isoform, and are effective in the treatment of abnormal lipid metabolism, diabetes and other disorders. The present invention also provides addition salts of such cyclic aminophenylalkanoic acid derivatives and pharmaceutical compositions containing these compounds.
Specifically, the present invention provides cyclic aminophenylalkanoic acid derivatives represented by the following general formula (1) :
or pharmaceutically acceptable salts thereof.摘要翻译: 本发明提供作为人过氧化物酶体增殖物激活受体(PPAR),特别是人PPARα同种型的激动剂起作用的环氨基苯基链烷酸衍生物,并且可有效治疗异常脂质代谢,糖尿病和其他病症。 本发明还提供了这种环状氨基苯基链烷酸衍生物的加成盐和含有这些化合物的药物组合物。 具体而言,本发明提供由以下通式(1)表示的环状氨基苯基链烷酸衍生物或其药学上可接受的盐。
-
公开(公告)号:EP1780210A1
公开(公告)日:2007-05-02
申请号:EP05770805.9
申请日:2005-08-11
发明人: NOMURA, Masahiro , TAKANO, Yasuo , YUMOTO, Kazuhiro , SHINOZAKI, Takehiro , ISOGAI, Shigeki , MURAKAMI, Koji
IPC分类号: C07D417/12 , A61K31/427 , A61K31/454 , A61K31/55 , A61P3/04 , A61P3/06 , A61P3/10 , A61P9/10 , A61P43/00 , C07D211/56 , A61K31/451 , C07D211/26 , C07D211/60 , C07D211/42 , C07D211/22
CPC分类号: C07D417/12 , C07D211/22 , C07D211/26 , C07D211/42 , C07D211/56 , C07D211/60
摘要: The present invention relates to cyclic amino benzoic acid derivatives which are effective in therapy of lipid metabolism abnormality, diabetes and the like as a human peroxisome proliferators-activated receptor (PPAR) agonist, in particular, as an agonist against human PPARα isoform, and addition salts thereof, and pharmaceutical compositions containing these compounds.
A cyclic amino benzoic acid derivative represented by the general formula (1)
[wherein a ring Ar represents an aryl group which may have substituent, or the like; Y represents a C 1 -C 4 alkylene, C 2 -C 4 alkenylene, C 2 -C 4 alkynylene, or the like; Z represents an oxygen atom, sulfur atom or - (CH 2 ) n - (n represents 0,1 or 2) ; X represents a hydrogen atom, halogen atom, lower alkyl group which may be substituted with a halogen atom, or the like; R represents a hydrogen atom or lower alkyl group, and -COOR substitutes for an ortho position or metha position of binding position of ring W] or a pharmaceutically acceptable salt thereof.摘要翻译: 本发明涉及有效治疗脂质代谢异常的环状氨基苯甲酸衍生物,作为人类过氧化物酶体增殖物激活受体(PPAR)激动剂的糖尿病等,特别是作为人PPAR +同工型的激动剂,以及 其加成盐,以及含有这些化合物的药物组合物。 由通式(1)表示的环状氨基苯甲酸衍生物[其中,环Ar表示可具有取代基的芳基等, Y代表C 1 -C 4亚烷基,C 2 -C 4亚烯基,C 2 -C 4亚炔基等; Z表示氧原子,硫原子或 - (CH 2)n - (n表示0,1或2); X表示氢原子,卤素原子,可被卤素原子取代的低级烷基等; R代表氢原子或低级烷基,-COOR代替环W的结合位置的邻位或甲基位置]或其药学上可接受的盐。
-
公开(公告)号:EP2013182B1
公开(公告)日:2013-09-04
申请号:EP07753130.9
申请日:2007-03-13
发明人: COCIORVA, Oana , LI, Bei , SZARDENINGS, Anna Katrin , FUKUDA, Yasumichi , NOMURA, Masahiro , SETO, Shigeki , YUMOTO, Kazuhiro , OKADA, Kyoko , NAKAMURA, Ayako
IPC分类号: C07D215/38 , C07D215/56 , C07D401/12 , C07D401/14 , C07D498/06 , A61K31/47 , A61K31/4709 , A61K31/538 , A61P25/00
CPC分类号: C12N9/99 , C07D498/06
-
公开(公告)号:EP2203459A1
公开(公告)日:2010-07-07
申请号:EP08830522.2
申请日:2008-09-12
发明人: COCIORVA, Oana , FUKUDA, Yasumichi , KOHNO, Yasushi , LI, Bei , OKADA, Kyoko , NAKAMURA, Ayako , NOMURA, Masahiro , SETO, Shigeki , SZARDENINGS, Katrin , YUMOTO, Kazuhiro
IPC分类号: C07D498/10 , C07D498/20 , A61K31/4747 , A61P25/00
CPC分类号: C07D498/06 , A61J1/00 , C07D498/10 , C07D498/20
摘要: Provided herein are spirocyclic aminoquinolones of formula I and compositions containing the compounds. The compounds and compositions provided herein are useful in the prevention, amelioration or treatment of GSK- 3 inhibitors mediated diseases. In Formula (I): X1 is O or NR8; A is bond or substituted or unsubstituted C1-C2 alkylene, wherein the substituents when present are selected from one to four Q2 groups; where Q2 is alkyl or haloalkyl; p is 0 or 1; and q is an integer of 0 to 2.
摘要翻译: 本文提供式I的螺环氨基喹诺酮和含有该化合物的组合物。 本文提供的化合物和组合物可用于预防,改善或治疗GSK-3抑制剂介导的疾病。 在式(I)中:X1是O或NR8; A是键或取代或未取代的C 1 -C 2亚烷基,其中存在时的取代基选自1至4个Q 2基团; 其中Q 2是烷基或卤代烷基; p是0或1; q是0〜2的整数。
-
-
-
-
-